MYLAN FDA Approval ANDA 212913

ANDA 212913

MYLAN

FDA Drug Application

Application #212913

Application Sponsors

ANDA 212913MYLAN

Marketing Status

Prescription001

Application Products

001SUSPENSION;ORAL1GM/10ML0SUCRALFATESUCRALFATE

FDA Submissions

UNKNOWN; ORIG1AP2022-09-12STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

MYLAN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212913
            [companyName] => MYLAN
            [docInserts] => ["",""]
            [products] => [{"drugName":"SUCRALFATE","activeIngredients":"SUCRALFATE","strength":"1GM\/10ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/12\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-09-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.